Stocks

The table gives an overview of all stocks, alphabetically sorted.
 AB INBEV ABI Jan 15, 2021 56.74 -0.39   
 Ackermans & van Haaren NV ACKB Jan 15, 2021 129.50 -0.77   
 Aedifica SA AED Jan 15, 2021 96.30 +0.42   
 Ageas AGS Jan 15, 2021 45.64 +0.26   
 APERAM APAM Jan 15, 2021 35.59 -2.39   
 Argen X SE ARGX Jan 15, 2021 231.40 +0.78   
 Barco NV BAR Jan 15, 2021 18.22 -1.59   
 Bel20 BEL20 Jan 15, 2021 3 715.69 -0.66   
 Cofinimmo COFB Jan 15, 2021 124.20 -0.16   
 Colruyt SA COLR Jan 15, 2021 50.72 -0.31   
 GALAPAGOS GLPG Jan 15, 2021 82.42 -1.79   
 Groupe Bruxelles Lambert SA GBLB Jan 15, 2021 83.80 -0.71   
 ING GROEP N.V. INGA Jan 15, 2021 7.85 -0.13   
 KBC Groep NV KBC Jan 15, 2021 60.20 -2.21   
 Proximus SADP PROX Jan 15, 2021 17.22 -0.40   
 Sofina SA SOF Jan 15, 2021 267.00 -0.19   
 Solvay SA SOLB Jan 15, 2021 99.54 -1.00   
 Telenet Group Holding NV TNET Jan 15, 2021 34.90 -0.06   
 UCB SA UCB Jan 15, 2021 86.84 -1.43   
 Umicore SA UMI Jan 15, 2021 45.40 -0.72   
 Warehousing & Distribution De Pauw WDP Jan 15, 2021 28.16 -0.14   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK